Michael Schönhofen
Directeur/Membre du Conseil chez FRESENIUS KABI ONCOLOGY LTD
Profil
Michael Schönhofen is currently working as a Non-Executive Director at Fresenius Kabi Oncology Ltd.
since 2010.
He is also currently serving as the President-Biopharma at Fresenius Kabi AG.
In terms of education, Dr. Schönhofen holds a doctorate degree from Technische Universität Darmstadt.
Postes actifs de Michael Schönhofen
| Sociétés | Poste | Début |
|---|---|---|
| FRESENIUS KABI ONCOLOGY LTD | Directeur/Membre du Conseil | 11/08/2008 |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Corporate Officer/Principal | - |
Formation de Michael Schönhofen
| Technische Universität Darmstadt | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Fresenius Kabi Oncology Ltd.
 Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Fresenius Kabi Oncology Ltd. is a research and development company, which engages in manufacturing and development of oncology drugs. It also develops active pharmaceutical ingredients, intermediates and oral and injectable finished dosage forms. The company was founded on March 18, 2003 and is headquartered in Gurgaon, India. | Commercial Services |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
